Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Grassi

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Current Medicinal Chemistry|July 16, 2013
Improving drug efficacy and specificity by innovative drug delivery approachesGabriele Grassi, Mario Grassi
Current Medicinal Chemistry|December 21, 2020
Drug Repurposing in Human CancersGabriele Grassi, Mario Grassi
Expert Opinion on Drug Delivery|June 19, 2014
Application of mathematical modeling in sustained release delivery systemsMario Grassi, Gabriele Grassi
Lancet (London, England)|May 11, 2013
First-in-human trial of Dz13 for nodular basal-cell carcinomaGabriele Grassi, Mario Grassi
Current Drug Delivery|November 25, 2005
Mathematical modelling and controlled drug delivery: matrix systemsMario Grassi, Gabriele Grassi
International Journal of Molecular Sciences|May 27, 2023
Zebrafish as an Experimental Model for Human DiseaseFederica Tonon, Gabriele Grassi
World Journal of Gastroenterology|July 1, 2024
New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs?Domenico Tierno, Gabriele Grassi, Bruna Scaggiante
Hepatobiliary Surgery and Nutrition|September 10, 2014
Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Barbara Dapas, Mario Grassi, Gabriele Grassi
Methods and Findings in Experimental and Clinical Pharmacology|May 21, 2009
Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cellsGiorgia Racchi, Karin Klingel, Reinhard Kandolf, et al.
The FEBS Journal|May 13, 2006
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell linesBruna Scaggiante, Barbara Dapas, Gabriele Grassi, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Current Medicinal Chemistry|July 16, 2013
Improving drug efficacy and specificity by innovative drug delivery approachesGabriele Grassi, Mario Grassi
Current Medicinal Chemistry|December 21, 2020
Drug Repurposing in Human CancersGabriele Grassi, Mario Grassi
Expert Opinion on Drug Delivery|June 19, 2014
Application of mathematical modeling in sustained release delivery systemsMario Grassi, Gabriele Grassi
Lancet (London, England)|May 11, 2013
First-in-human trial of Dz13 for nodular basal-cell carcinomaGabriele Grassi, Mario Grassi
Current Drug Delivery|November 25, 2005
Mathematical modelling and controlled drug delivery: matrix systemsMario Grassi, Gabriele Grassi
International Journal of Molecular Sciences|May 27, 2023
Zebrafish as an Experimental Model for Human DiseaseFederica Tonon, Gabriele Grassi
World Journal of Gastroenterology|July 1, 2024
New challenges in hepatocellular carcinoma: A role for PIWI-interacting RNAs?Domenico Tierno, Gabriele Grassi, Bruna Scaggiante
Hepatobiliary Surgery and Nutrition|September 10, 2014
Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?Barbara Dapas, Mario Grassi, Gabriele Grassi
Methods and Findings in Experimental and Clinical Pharmacology|May 21, 2009
Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cellsGiorgia Racchi, Karin Klingel, Reinhard Kandolf, et al.
The FEBS Journal|May 13, 2006
Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell linesBruna Scaggiante, Barbara Dapas, Gabriele Grassi, et al.
Pageof 13